PLN and cardiomyopathy: Though pathogenic variants in PLN are rare, findings from PLN mutant carriers and mouse models demonstrate that changes in calcium handling in the presence of Phospholamban pathogenic variants, secondary to perturbations in SERCA2a activity, are sufficient to cause cardiomyopathy.